Surface-Exposed Adeno-Associated Virus Vp1-NLS Capsid Fusion Protein Rescues Infectivity of Noninfectious Wild-Type Vp2/Vp3 and Vp3-Only Capsids but Not That of Fivefold Pore Mutant Virions
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Over the past 2 decades, significant effort has been dedicated to the development of adeno-associated virus (AAV) as a vector for human gene therapy. However, understanding of the virus with respect to the functional domains of the capsid remains incomplete. In this study, the goal was to further examine the role of the unique Vp1 N terminus, the N terminus plus the recently identified nuclear localization signal (NLS) (J. C. Grieger, S. Snowdy, and R. J. Samulski, J. Virol 80 :5199-5210, 2006), and the virion pore at the fivefold axis in infection. We generated two Vp1 fusion proteins (Vp1 and Vp1NLS) linked to the 8-kDa chemokine domain of rat fractalkine (FKN) for the purpose of surface exposure upon assembly of the virion, as previously described (K. H. Warrington, Jr., O. S. Gorbatyuk, J. K. Harrison, S. R. Opie, S. Zolotukhin, and N. Muzyczka, J. Virol 78 :6595-6609, 2004). The unique Vp1 N termini were found to be exposed on the surfaces of these capsids and maintained their phospholipase A2 (PLA2) activity, as determined by native dot blot Western and PLA2 assays, respectively. Incorporation of the fusions into AAV type 2 capsids lacking a wild-type Vp1, i.e., Vp2/Vp3 and Vp3 capsid only, increased infectivity by 3- to 5-fold (Vp1FKN) and 10- to 100-fold (Vp1NLSFKN), respectively. However, the surface-exposed fusions did not restore infectivity to AAV virions containing mutations at a conserved leucine (Leu336Ala, Leu336Cys, or Leu336Trp) located at the base of the fivefold pore. EM analyses suggest that Leu336 may play a role in global structural changes to the virion directly impacting downstream conformational changes essential for infectivity and not only have local effects within the pore, as previously suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The pore at the 5-fold axes is postulated to be the site for externalization of the PLA2 enzyme within VP1u required for endosomal escape during infection and for genome packaging and release during infection (Bleker et al., 2005; Grieger et al., 2007; Kronenberg et al., 2005; Sonntag et al., 2006).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Grieger et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
SWISS-MODEL: an automated protein homology-modeling server
Schwede, T. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg520 · Cited by 5,606
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406 · cited 1×
“The early steps of AAV2 infection begin with attachment to heparan sulfate proteoglycan and to a variety of cell surface receptors, such as FGFR, V 5 integrin, 5 1 integrin, and hepatocyte growth factor receptor (c-Met) (4, 14, 22, 32, 38, 39), followed by clathrin dependent endocytosis.”
BackgroundSelf-citationZolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312 · cited 1×
“loaded onto iodixanol step gradients as described previously (53).”
MethodSelf-citationAdenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Jones, N., & Shenk, T. (1979) · Cell · doi:10.1016/0092-8674(79)90275-7 · Cited by 760
Nucleotide sequence and organization of the adeno-associated virus 2 genome
Srivastava, A., Lusby, E. W., & Berns, K. I. (1983) · Journal of Virology · doi:10.1128/jvi.45.2.555-564.1983 · Cited by 721 · cited 2×
“Vp1, Vp2, and Vp3 are incorporated into capsids at a predicted ratio of 1:1:8 and have overlapping sequences, differing only at their N termini.”
BackgroundαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Self-citationThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612 · cited 1×
“The parvovirus virion is composed of 60 subunits of the overlapping Vp ( 530 C-terminal amino acids) region arranged with T 1 icosahedral symmetry (25, 48).”
BackgroundA Viral Phospholipase A2 Is Required for Parvovirus Infectivity
Zádori, Z., Szelei, J., Lacoste, M.-C., Li, Y., Gariépy, S., Raymond, P., Allaire, M., Nabi, I. R., & Tijssen, P. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00031-4 · Cited by 518 · cited 4×
“The unique N terminus of Vp1 contains a conserved PLA2 domain (8, 15, 18, 28, 52) that is essential for infectivity and is thought to be required for endosomal escape.”
BackgroundInfluential
Cited by
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 551
Self-citationGene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306
Intracellular transport of recombinant adeno-associated virus vectors
Nonnenmacher, M., & Weber, T. (2012) · Gene Therapy · doi:10.1038/gt.2012.6 · Cited by 258
Erratum: Gene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.158 · Cited by 248
Venkatakrishnan, B., Yarbrough, J., Domsic, J., Bennett, A., Bothner, B., Kozyreva, O. G., Samulski, R. J., Muzyczka, N., McKenna, R., & Agbandje-McKenna, M. (2013) · Journal of Virology · doi:10.1128/jvi.02524-12 · Cited by 225
Self-citationRecombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 215
AAV Capsid Structure and Cell Interactions
Agbandje-McKenna, M., & Kleinschmidt, J. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_3 · Cited by 215
Self-citationTwenty-Five Years of Structural Parvovirology
Mietzsch, M., Pénzes, J. J., & Agbandje-McKenna, M. (2019) · Viruses · doi:10.3390/v11040362 · Cited by 197
“This mutant has a genome packaging defect and altered VP1u externalization properties [80].”
BackgroundSelf-citationAdeno-Associated Virus Vectorology, Manufacturing, and Clinical Applications
Grieger, J. C., & Samulski, R. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00012-0 · Cited by 199
“The unique N-termini of VP1 and VP2 both contain nuclear localization signals required for the nuclear transport of the capsid (Grieger et al., 2007).”
BackgroundSelf-citationEnhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus
Johnson, J. S., & Samulski, R. J. (2009) · Journal of Virology · doi:10.1128/jvi.02309-08 · Cited by 162
“ously described (25), HeLa cells (5 10(4)/well) were plated on poly-L-lysine-”
MethodSelf-citationAdeno-Associated Viral Vectors and Their Redirection to Cell-Type Specific Receptors
Michelfelder, S., & Trepel, M. (2009) · Advances in genetics · doi:10.1016/s0065-2660(09)67002-4 · Cited by 149
Recombinant Adeno-Associated Virus Utilizes Host Cell Nuclear Import Machinery To Enter the Nucleus
Nicolson, S. C., & Samulski, R. J. (2014) · Journal of Virology · doi:10.1128/jvi.02660-13 · Cited by 114
“Incorporating one of the BR domains (BR3) into rAAV2 particles lacking VP1up has been shown to partially rescue the infectivity of these mutant virions (87).”
BackgroundSelf-citationNam, H.-J., Gurda, B. L., McKenna, R., Potter, M., Byrne, B., Salganik, M., Muzyczka, N., & Agbandje-McKenna, M. (2011) · Journal of Virology · doi:10.1128/jvi.05305-11 · Cited by 108
“However, the 2-fold axis has not been previously implicated in the events associated with endosomal processing of the parvovirus capsid, such as the externalization of VP1u and VP2 N termini or genome uncoating, since the 5-fold pore is predicted to be a portal for these exposures (5, 21, 28, 45).”
BackgroundSelf-citationJohnson, J. S., Li, C., DiPrimio, N., Weinberg, M. S., McCown, T. J., & Samulski, R. J. (2010) · Journal of Virology · doi:10.1128/jvi.00687-10 · Cited by 105
“Similar to what we have previously described (26), HeLa cells (5 10(4) cells/well) were plated onto poly-L-lysine-”
MethodSelf-citationAAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
M. Mitchell, A., C. Nicolson, S., K. Warischalk, J., & Jude Samulski, R. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 96
“In addition to the common region shared by all three capsid proteins, VP1 and VP2 both contain nuclear localization signals (NLS) required for the nuclear transport of the capsid [79, 80].”
BackgroundSelf-citationMapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8
Gurda, B. L., Raupp, C., Popa-Wagner, R., Naumer, M., Olson, N. H., Ng, R., McKenna, R., Baker, T. S., Kleinschmidt, J. A., & Agbandje-McKenna, M. (2012) · Journal of Virology · doi:10.1128/jvi.00218-12 · Cited by 93
Self-citationBarnes, L. F., Draper, B. E., Chen, Y., Powers, T. W., & Jarrold, M. F. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.08.002 · Cited by 92
Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
Tan, Y. Z., Aiyer, S., Mietzsch, M., Hull, J. A., McKenna, R., Grieger, J., Samulski, R. J., Baker, T. S., Agbandje-McKenna, M., & Lyumkis, D. (2018) · Nature Communications · doi:10.1038/s41467-018-06076-6 · Cited by 84
Self-citationEvidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid
Salganik, M., Venkatakrishnan, B., Bennett, A., Lins, B., Yarbrough, J., Muzyczka, N., Agbandje-McKenna, M., & McKenna, R. (2012) · Journal of Virology · doi:10.1128/jvi.01717-12 · Cited by 80
“357 One consequence of passage through the acidic endosomal compartment is the 358 extrusion of the N terminus of VP1, which contains both nuclear localization sites and a 359 phospholipase activity that are essential for infection (5, 6, 11).”
BackgroundSelf-citationCellular transduction mechanisms of adeno-associated viral vectors
Berry, G. E., & Asokan, A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.08.001 · Cited by 78
Salganik, M., Aydemir, F., Nam, H.-J., McKenna, R., Agbandje-McKenna, M., & Muzyczka, N. (2014) · Journal of Virology · doi:10.1128/jvi.02093-13 · Cited by 73
Self-citationThe parvovirus capsid odyssey: from the cell surface to the nucleus
Harbison, C. E., Chiorini, J. A., & Parrish, C. R. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.01.012 · Cited by 93
Hsu, H.-L., Brown, A., Loveland, A. B., Lotun, A., Xu, M., Luo, L., Xu, G., Li, J., Ren, L., Su, Q., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17047-1 · Cited by 63
Adeno-associated virus capsid antigen presentation is dependent on endosomal escape
Li, C., He, Y., Nicolson, S., Hirsch, M., Weinberg, M. S., Zhang, P., Kafri, T., & Samulski, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66611 · Cited by 61
Self-citationNanocarrier‐Based Systems for Targeted Delivery: Current Challenges and Future Directions
Xu, Z., Xie, Y., Chen, W., & Deng, W. (2025) · MedComm · doi:10.1002/mco2.70337 · Cited by 88
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Wert, K. J., Davis, R. J., Sancho-Pelluz, J., Nishina, P. M., & Tsang, S. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds466 · Cited by 55
Chen, H., Dou, Y., Tang, Y., Zheng, X., Niu, X., Yang, J., Yu, X., & Diao, Y. (2015) · Veterinary Microbiology · doi:10.1016/j.vetmic.2015.11.034 · Cited by 55
Drouin, L. M., Lins, B., Janssen, M., Bennett, A., Chipman, P., McKenna, R., Chen, W., Muzyczka, N., Cardone, G., Baker, T. S., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00575-16 · Cited by 52
“However, chimeric AAV2 variants with externalized VP1 and VP2 still maintain wt packaging efficiencies (5, 42, 43).”
Self-citationOptimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system
Bosma, B., du Plessis, F., Ehlert, E., Nijmeijer, B., de Haan, M., Petry, H., & Lubelski, J. (2018) · Gene Therapy · doi:10.1038/s41434-018-0034-7 · Cited by 52
Judd, J., Wei, F., Nguyen, P. Q., Tartaglia, L. J., Agbandje-McKenna, M., Silberg, J. J., & Suh, J. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.46 · Cited by 51
Self-citationSurface Loop Dynamics in Adeno-Associated Virus Capsid Assembly
DiPrimio, N., Asokan, A., Govindasamy, L., Agbandje-McKenna, M., & Samulski, R. J. (2008) · Journal of Virology · doi:10.1128/jvi.02721-07 · Cited by 49
“Mutagenesis of residues that constitute the pore has suggested a critical role in assembly and packaging (8, 17, 55).”
BackgroundResultSelf-citationJohnson, J. S., Gentzsch, M., Zhang, L., Ribeiro, C. M. P., Kantor, B., Kafri, T., Pickles, R. J., & Samulski, R. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002053 · Cited by 48
Self-citationStructures and Functions of Parvovirus Capsids and the Process of Cell Infection
Parrish, C. R. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_33 · Cited by 56
“VP2 terminal exposure appears to be a dynamic process that relies on the opening and closing of the pore, and it is also temperature dependent, and VP2 and DNA exposure can both be modified by mutations of residues within the pore (Farr et al. 2006; Farr and Tattersall 2004; Grieger et al. 2007).”
BackgroundKeiser, N. W., Yan, Z., Zhang, Y., Lei-Butters, D. C. M., & Engelhardt, J. F. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.044 · Cited by 40
“This conformational change is also thought to expose a nuclear localization signal within the capsid, promoting import of the virus into the nucleus following its release into the cytoplasm (Grieger et al., 2007).”
InfluentialAdeno-Associated Virus Vectors and Stem Cells: Friends or Foes?
Brown, N. J., Song, L., Rao, K. N., & Hirsch, M. L. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.038 · Cited by 43
Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery
Gonzalez, T. J., Mitchell-Dick, A., Blondel, L. O., Fanous, M. M., Hull, J. A., Oh, D. K., Møller-Tank, S., Rivera, R. M. C., Piedrahita, J. A., & Asokan, A. (2023) · Nature Protocols · doi:10.1038/s41596-023-00875-y · Cited by 42
Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2
Bennett, A., Keravala, A., Makal, V., Kurian, J., Belbellaa, B., Aeran, R., Tseng, Y.-S., Sousa, D., Spear, J., Gasmi, M., et al. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.107433 · Cited by 33
“The pore at the 5-fold axes is postulated to be the site for externalization of the PLA2 enzyme within VP1u required for endosomal escape during infection and for genome packaging and release during infection (Bleker et al., 2005; Grieger et al., 2007; Kronenberg et al., 2005; Sonntag et al., 2006).”
BackgroundSelf-citationPhospholipases and Membrane Curvature: What Is Happening at the Surface?
Fanani, M. L., & Ambroggio, E. E. (2023) · Membranes · doi:10.3390/membranes13020190 · Cited by 36
“Capsid mutations that reduce exposure of the PLA2 domain dramatically decrease infectivity, and mutations of residues around the fivefold axis of symmetry that are predicted to relax the pore can restore transduction activity in mutant particles lacking VP1 [63,64].”
BackgroundCapsid-mediated control of adeno-associated viral transcription determines host range
Loeb, E. J., Havlik, P. L., Elmore, Z. C., Rosales, A., Fergione, S. M., Gonzalez, T. J., Smith, T. J., Benkert, A. R., Fiflis, D. N., & Asokan, A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113902 · Cited by 35
“Thus, the N-terminal domain of VP1, which remains buried within the AAV capsid lumen prior to cellular uptake, 34,35 appears to play a significant role in genome transcription.”
Hagen, S. H., Baumann, T., Wagner, H. J., Morath, V., Kaufmann, B., Fischer, A., Bergmann, S., Schindler, P., Arndt, K. M., & Müller, K. M. (2014) · Scientific Reports · doi:10.1038/srep03759 · Cited by 38
Onishi, T., Nonaka, M., Maruno, T., Yamaguchi, Y., Fukuhara, M., Torisu, T., Maeda, M., Abbatiello, S. E., Haris, A., Richardson, K., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101142 · Cited by 34
“10,13,20,22,23 Phospholipase domains in this region speci fi cally hydrolyze the 2-acyl ester (sn-2) bonds of phospholipids that form the lipid bilayer of the endosome, resulting in endosomal escape of AAV.”
BackgroundHorowitz, E. D., Finn, M. G., & Asokan, A. (2012) · ACS Chemical Biology · doi:10.1021/cb3000265 · Cited by 31
“In contrast, similar mutagenesis studies carried out in AAV2 capsids report a decrease in pore flexibility, which prevents VP1u domain exposure (6, 12).”
BackgroundResultInfluentialAdeno-Associated Virus VP1u Exhibits Protease Activity
Kurian, J. J., Lakshmanan, R., Chmely, W. M., Hull, J. A., Yu, J. C., Bennett, A. D., McKENNA, R. V., & Agbandje‐McKenna, M. (2019) · Viruses · doi:10.3390/v11050399 · Cited by 25
“Significantly, the protease activity within the VP1u occurs without applying an external treatment, for example, heat, to the capsid to “externalize” this VP region as reported to be required for PLA2 activity in assays outside a cell [28].”
BackgroundSelf-citationBackovic, A., Cervelli, T., Salvetti, A., Zentilin, L., Giacca, M., & Galli, A. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-124 · Cited by 30
Giles, A. R., Lock, M. W., Chen, S., Turner, K. B., Wesolowski, G. A., Prongay, A., Petkov, B., Olagbegi, K., Yan, H., & Wilson, J. M. (2023) · Human Gene Therapy · doi:10.1089/hum.2022.116 · Cited by 23
Qizhao, W., Firrman, J., Wu, Z., Pokiniewski, K. A., Valencia, C. A., Wang, H., Wei, H., Zhuang, Z., Liu, L., Wunder, S. L., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.055 · Cited by 20
N-glycomic profiling of capsid proteins from Adeno-Associated Virus serotypes
Xie, Y., & Butler, M. (2023) · Glycobiology · doi:10.1093/glycob/cwad074 · Cited by 18
“VP2/VP3 and VP3-only cap-sids have been found to be non-infectious, whereas VP1 maintains infectivity (Grieger et al.2007).”
BackgroundThe Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs)
Küz, Ç. A., McFarlin, S., & Qiu, J. (2024) · Viruses · doi:10.3390/v16081215 · Cited by 18
Probing recombinant AAV capsid integrity and genome release after thermal stress by mass photometry
Ebberink, E. H. T. M., Ruisinger, A., Nuebel, M., Meyer‐Berg, H., Ferreira, I. R. S., Thomann, M., & Heck, A. J. R. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101293 · Cited by 18
Stoute, S. T., Tsai, H., Metwally, S. A., Cheng, A., Guérin, J., & Palya, V. (2019) · Wiley eBooks · doi:10.1002/9781119371199.ch13 · Cited by 16
Ikeda, T., Yamaguchi, Y., Oyama, H., Matsushita, A., Tsunaka, Y., Fukuhara, M., Torisu, T., & Uchiyama, S. (2024) · Viruses · doi:10.3390/v16040585 · Cited by 12
“…N-terminal regions, which are supposed to be located Viruses 2024 , 16 , 585 2 of 15 inside the capsid prior to rAAV infection, are externalized in order to exert their functions, such as phospholipase A2 activity for endosomal escape and nuclear localization signaling to enter the nucleus [10,11].”
BackgroundStructural basis for nuclear import of adeno-associated virus serotype 6 capsid protein
Hoad, M., Nematollahzadeh, S., Petersen, G. F., Roby, J. A., Alvisi, G., & Forwood, J. K. (2024) · Journal of Virology · doi:10.1128/jvi.01345-24 · Cited by 17
Adeno-Associated Virus-Mediated Gene Therapy
Zaman, H., Khan, A. U., Khan, K., Toheed, S., Abdullah, M., Zeeshan, H. M., Hameed, A., Umar, M., Shahid, M., Malik, K. A., et al. (2023) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2023048135 · Cited by 12
Recombination and Population Mosaic of a Multifunctional Viral Gene, Adeno-Associated Virus cap
Takeuchi, Y., Myers, R. E., & Danos, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001634 · Cited by 13
“The additional domains of VP1 and VP2 are buried inside the capsid in the native virions and become surface exposed during trafficking through the endosomal system [5–7].”
BackgroundHoad, M., Roby, J. A., & Forwood, J. K. (2021) · FEBS Letters · doi:10.1002/1873-3468.14209 · Cited by 10
Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors
Chai, Z., Zhang, X., Dobbins, A., Frost, E. A., Samulski, R., & Li, C.-W. (2019) · Viruses · doi:10.3390/v11121138 · Cited by 10
“Earlier studies showed that VP1 played an important role for virus infectivity or stability [16,17], while both VP2 and VP3 were required for capsid formation [18].”
BackgroundSelf-citationReprogramming the Activatable Peptide Display Function of Adeno-Associated Virus Nanoparticles
Thadani, N. N., Dempsey, C., Zhao, J. X., Vasquez, S. M., & Suh, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b07804 · Cited by 9
Interaction of parvoviruses with the nuclear envelope
Snoussi, K., & Kann, M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.008 · Cited by 10
The amazing AAV capsids: Into the structure-verse
Hsi, J., Mietzsch, M., & McKENNA, R. V. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101629 · Cited by 12
“15 The VP1u contains an essential phospholipase A2 (PLA 2 ) domain, 21 and the VP1/2 common region contains nuclear localization signals, 22,23 both of which are critical in the AAV viral life cycle.”
Structural basis for nuclear import of bat adeno-associated virus capsid protein
Hoad, M., Roby, J. A., & Forwood, J. K. (2024) · Journal of General Virology · doi:10.1099/jgv.0.001960 · Cited by 8
Adeno-associated virus vectors for human gene therapy
Chen, H. (2015) · World Journal of Medical Genetics · doi:10.5496/wjmg.v5.i3.28 · Cited by 9
Duran, T., Naik, S., Sharifi, L., DiLuzio, W. R., Chanda, A., & Chaudhuri, B. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123985 · Cited by 6
Protein Carrier Adeno-Associated Virus
Hoffmann, M. D., Sorensen, R. J., Extross, A., He, Y., & Schmidt, D. (2025) · ACS Nano · doi:10.1021/acsnano.5c01498 · Cited by 6
Thyashan, N., Manawasinghe, J., Gu, C., Khatri, S., Nelson, C., Sanli, M. E., Gray, S. J., Lee, S., Dutta, P., Alexandrakis, G., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c16533 · Cited by 5
Arriaga, I., Navarro, A., Etxabe, A., Trigueros, C., Samulski, R. J., Moullier, P., François, A., & Abrescia, N. G. A. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.119 · Cited by 11
“58 Surprisingly, we observed a 10-fold drop in AAV3B VP2 knockout virions suggesting a role for this subunit in AAV infection.”
Self-citationHoad, M., Nematollahzadeh, S., Roby, J. A., Alvisi, G., & Forwood, J. K. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101630 · Cited by 3
“57 This shorter N-terminus construct was used due to its predictive flexibility (common with NLS location on proteins) and the significant ease of use compared to complexing and crystallizing a fully assembled AAV capsid.”
Hull, J. A., Fusco, R. M., Tan, J., Ochoa, M. A., Hall, A., Wan, X., Loeb, E., & Asokan, A. (2025) · Journal of Virology · doi:10.1128/jvi.00799-25 · Cited by 3
Viral Vectors for Gene Delivery
Dismuke, D. J., Gray, S. J., Hirsch, M. L., Samulski, R. J., & Muzyczka, N. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732239-00338 · Cited by 3
Self-citationScreening of a retinal-targeting Adeno-Associated Virus (AAV) via DNA shuffling
Yu, Y., Zhou, X., Peng, W., Wang, Y., Li, M., Zhu, Y., Song, Z., Wu, F., & Dong, C. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110245 · Cited by 3
Ebberink, E. H. T. M., Ruisinger, A., Nuebel, M., Meyer‐Berg, H., Ferreira, I. R. S., Thomann, M., & Heck, A. J. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.07.583968 · Cited by 2
Parambathu, A. V., Kumar, V., Khanal, O., & Lenhoff, A. M. (2025) · Molecular Therapy Advances · doi:10.1016/j.omta.2025.201656 · Cited by 2
“32 Nevertheless, it still appears that the VP12u region is internalized during production.”
Serotype 8 Capsid of Adeno-Associated Virus Mapping a Neutralizing Epitope onto the
Agbandje‐McKenna, M., Baker, T. S., Kleinschmidt, J. A., Naumer, M., Olson, N. H., Ng, R., Gurda, L., Raupp, C., & Popa-Wagner, R. (2012)
Self-citation[Capsid assembly and DNA encapsidation of adeno-associated virus].
Qizhao, W., Lü, Y., Li, Z., Diao, Y., & Xu, R. (2011) · PubMed
Chemical Modulation of AAV Trafficking
Berry, G. E. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/dpe3-gy73
Therapy and mechanism of Mendelian eye diseases
Tsai, Y.-T. (2018) · Columbia Academic Commons (Columbia University) · doi:10.7916/d8k37bhv
Nicolson, S. C. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gbv4-z740
Adeno-associated virus-mediated gene therapy in central nervous system genetic disorders
Casy, W., Ling, Q., Shaffo, F. C., Sinnett, S. E., & Gray, S. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00010-6 · Cited by 1
Silveria, M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94095
Zeng, F., Liu, Q., Wang, X., Zhong, P., Wu, P., Yang, M., & Wei, P. (2025) · Virology · doi:10.1016/j.virol.2025.110653
Intracellular trafficking and nuclear compartmentalization of AAV gene delivery
Hutchinson, T. E., Singh, R. E., Oliver, J. Y., Davis, A., Potter, M., Hsi, J., Mietzsch, M., Bennett, A. D., & McKenna, R. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201770
“This is consistent with the known role of VP1u with regard to the escape of the endosome and NLS. 7 The two variants, AAV2-Y704A 25 and AAV2-E563A, 61,77 which Figure 7.”
Olarewaju, O., Bentler, M., Breuer, J., Alioglu, F., Grabowski, A., Prosche, A., Sami, H., Ogris, M., & Büning, H. (2026) · Human Gene Therapy · doi:10.1177/10430342261465461
“27,28 Lipolytic pore formation mediated by the enzymatic activity of the PLA2 domain releases the AAV particle from the trans-Golgi network or endosomes into the cyto-sol.”
Metadata
- Authors
- Grieger, J. C., Johnson, J. S., Gurda-Whitaker, B., Agbandje-McKenna, M., & Samulski, R. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-08
- Volume
- 81
- Issue
- 15
- Pages
- 7833-7843
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1951316
- OpenAlex
- W2136568935
- Cited by
- 83
- References
- 56
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 6 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 9
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5p01gm059299-10)
- National Heart, Lung, and Blood Institute (P01HL059412, P01HL051811, HL 51811., P01HL066973, P01 HL 59412, HL 066973)
- National Institute of General Medical Sciences (P01 GM-059299, GM059299)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30‐DK34987, P30DK034987, P30DK065988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Keywords
- adeno-associated virus, AAV capsid, nuclear localization signal, phospholipase A2 activity, gene therapy vectors
- MeSH terms
- Dependovirus, Amino Acid Sequence, Animals, Capsid, Cell Line, Humans, Membrane Proteins, Models, Molecular, Recombinant Fusion Proteins, Virion, Nuclear Localization Signals, Chemokines, CX3C, Protein Structure, Quaternary, Capsid Proteins, Rats, Chemokine CX3CL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.